Integra LifeSciences Shares Plunge 21% on Preliminary Q3 Results

Key Facts

1Integra LifeSciences shares dropped 21% following the release of preliminary third-quarter financial results.

Integra LifeSciences shares dropped 21% following the release of preliminary third-quarter financial results for 2026. Seeking Alpha reported that the sell-off occurred after the company provided its preliminary update alongside a proposed $600 million debt refinancing.

IART closed at $16.09 on October 1, 2026, having reached a day high of $16.45 and a day low of $15.88. The significant price movement reflects investor reaction to the latest financial disclosures from the medical technology and surgical instrumentation firm.